CIRM Funded Clinical Trials

Phase 1 Clinical research program for functional cure of HIV with EBT-101, in-vivo gene therapy

Disease Area:
Investigator:
CIRM Grant:
CLIN2-13310 (Active)
Award Value:
$6,852,486.00
Trial Sponsor:
Excision BioTherapeutics
Trial Stage:
Phase 1
Trial Status:
Recruiting
Targeted Enrollment:
9
ClinicalTrials.gov ID:

CIRM Clinical Trial Resources


Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox


Video on Stem Cell Trials


Other Resources

ISSCR Patient Website

ClinicalTrials.gov